Elmar Nurmemmedov

Elmar Nurmemmedov

Company: Saint John’s Cancer Institute

Job title: Principal Investigator & Director of Drug Discovery


Join me at Wnt


Discovery of Direct Small-Molecule Modulators of β-Catenin 9:15 am

• Explaining why small-molecule direct modulators of β-catenin are an underexplored space • Highlighting that direct modulators of β-catenin provide novel pharmacology to target Wnt signaling • Apply β-catenin direct modulators to target oncology and regenerationRead more

day: Day One

New Ways to Attack an Armadillo – Latest Approaches to Inhibit β-Catenin Signaling 8:30 am

• Sharing lessons learned on the various therapeutic mechanisms • Explore different modalities including Creb, siRNA, PROTAC and bispecifics – what is the best route to tame Wnt and β-catenin? • Debate the optimal approach of cellular target engagementRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.